JP Morgan Chase’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21
| Closed | -$4 | – | 7524 |
|
|
2025
Q3 | $4 | Sell |
21
-189,073
| -100% | -$227K | ﹤0.01% | 7338 |
|
|
2025
Q2 | $321K | Buy |
189,094
+24,219
| +15% | +$40.9K | ﹤0.01% | 5002 |
|
|
2025
Q1 | $261K | Buy |
164,875
+164,854
| +785,019% | +$279K | ﹤0.01% | 5129 |
|
|
2024
Q4 | $38 | Hold |
21
| – | – | ﹤0.01% | 7178 |
|
|
2024
Q3 | $127 | Hold |
21
| – | – | ﹤0.01% | 6970 |
|
|
2024
Q2 | $110 | Hold |
21
| – | – | ﹤0.01% | 6870 |
|
|
2024
Q1 | $178 | Hold |
21
| – | – | ﹤0.01% | 6822 |
|
|
2023
Q4 | $139 | Sell |
21
-29,406
| -100% | -$145K | ﹤0.01% | 7089 |
|
|
2023
Q3 | $90.9K | Sell |
29,427
-14,446
| -33% | -$41.6K | ﹤0.01% | 5532 |
|
|
2023
Q2 | $118K | Sell |
43,873
-15,833
| -27% | -$46.4K | ﹤0.01% | 5384 |
|
|
2023
Q1 | $177K | Buy |
59,706
+50,955
| +582% | +$150K | ﹤0.01% | 5134 |
|
|
2022
Q4 | $22K | Sell |
8,751
-64,917
| -88% | -$186K | ﹤0.01% | 5852 |
|
|
2022
Q3 | $134K | Sell |
73,668
-206,057
| -74% | -$543K | ﹤0.01% | 5150 |
|
|
2022
Q2 | $882K | Buy |
279,725
+202,975
| +264% | +$1.13M | ﹤0.01% | 4189 |
|
|
2022
Q1 | $474K | Buy |
76,750
+62,558
| +441% | +$550K | ﹤0.01% | 4742 |
|
|
2021
Q4 | $202K | Buy |
14,192
+199
| +1% | +$2.22K | ﹤0.01% | 5348 |
|
|
2021
Q3 | $112K | Buy |
13,993
+12,417
| +788% | +$197K | ﹤0.01% | 5512 |
|
|
2021
Q2 | $45K | Buy |
1,576
+339
| +27% | +$9.85K | ﹤0.01% | 5763 |
|
|
2021
Q1 | $36K | Buy |
1,237
+85
| +7% | +$1.98K | ﹤0.01% | 5601 |
|
|
2020
Q4 | $14K | Sell |
1,152
-3,775
| -77% | -$26.6K | ﹤0.01% | 5352 |
|
|
2020
Q3 | $34K | Buy |
+4,927
| New | +$33.4K | ﹤0.01% | 5044 |
|